Mark Pearson - 13 Feb 2025 Form 4 Insider Report for Equitable Holdings, Inc. (EQH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Feb 2025, 17:36:24 UTC
Prior SEC filing
16 Jan 2025
Next SEC filing
04 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Brudoley as attorney-in-fact for Mark Pearson

Key filing fact

Mark Pearson filed Form 4 for Equitable Holdings, Inc. (EQH) on 18 Feb 2025.

Key facts

  • This page summarizes Mark Pearson's Form 4 filing for Equitable Holdings, Inc. (EQH).
  • 8 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Feb 2025, 17:36.

Change

  • Previous filing in this sequence was filed on 16 Jan 2025.
  • Current net transaction value: -$1,193,654.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EQH transaction

Common Stock

Award

Transaction value
$0
Shares
+94,524
Change %
+15%
Price
$0.000000
Shares after
724,463
Date
13 Feb 2025
Ownership
Direct
Footnotes
F1, F2
EQH transaction

Common Stock

Options Exercise

Transaction value
$463,600
Shares
+20,000
Change %
+2.8%
Price
$23.18
Shares after
744,463
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2, F3
EQH transaction

Common Stock

Sale

Transaction value
$32,397
Shares
-600
Change %
-0.08%
Price
$53.99
Shares after
743,863
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2, F3, F4
EQH transaction

Common Stock

Sale

Transaction value
$1,066,908
Shares
-19,300
Change %
-2.6%
Price
$55.28
Shares after
724,563
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2, F3, F5
EQH transaction

Common Stock

Sale

Transaction value
$5,578
Shares
-100
Change %
-0.01%
Price
$55.78
Shares after
724,463
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2, F3
EQH transaction

Common Stock

Sale

Transaction value
$23,250
Shares
-429
Change %
-0.06%
Price
$54.20
Shares after
724,034
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2, F3, F6
EQH transaction

Common Stock

Sale

Transaction value
$529,122
Shares
-9,571
Change %
-1.3%
Price
$55.28
Shares after
714,463
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2, F3, F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQH transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-20,000
Change %
-4.5%
Price
$0.000000
Shares after
426,400
Date
14 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$23.18
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

Grant of restricted stock units under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three ratable annual installments beginning on February 28, 2026. Vested shares will be delivered to the reporting person within 30 days following the vesting date.

Footnote F2

Total includes Restricted Stock Units.

Footnote F3

The sales reported and options exercised on this Form 4 were effected pursuany to a 10b5-1 trading plan adopted by the reporting person on May 30, 2024.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $53.7450 to $54.7300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F5

This transaction was executed in multiple trades at prices ranging from $54.7600 to $55.7500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F6

This transaction was executed in multiple trades at prices ranging from $53.8500 to $54.8200. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F7

This transaction was executed in multiple trades at prices ranging from $54.8800 to $55.7500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F8

Grant of employee stock option uncer the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .